Skip to main content
SpringerLink
Log in

Adjuvant Therapies in Women with Early Breast Cancer

  • Drug Economics and Quality of Life
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Early Breast Cancer Trialists’ Collaborative Group. Lancet 339: 1–15, 71–85, 1992

    Google Scholar 

  2. Bryson HM, Plosker GL. PharmacoEconomics 4: 40–66, 1993

    Article  PubMed  CAS  Google Scholar 

  3. Hillner BE, Smith TJ. Proceedings of the American Society of Clinical Oncology 11: 55, 1992

    Google Scholar 

  4. Smith TJ, Hillner BE. J Clin Oncol 11: 771–776, 1993

    PubMed  CAS  Google Scholar 

  5. Catherino WH, Jordan VC. Drug Saf 8: 381–397, 1993

    Article  PubMed  CAS  Google Scholar 

  6. Gelber RD, Goldhirsch A. J Clin Oncol 4: 1772–1779, 1986

    PubMed  CAS  Google Scholar 

  7. Goldhirsch A, et al. J Clin Oncol 7: 36–44, 1989

    PubMed  CAS  Google Scholar 

  8. Pritchard KI, et al. 26th Annual Meeting of the Americal Society of Clinical Oncology, Washington, May 20–22 1990. Abstract no. 154, p41, 1990

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adjuvant Therapies in Women with Early Breast Cancer. Drugs Ther. Perspect 2, 14–16 (1993). https://doi.org/10.2165/00042310-199302110-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199302110-00007

Search

Navigation